Answer a quick 5 minute survey to improve our website.
Rivaroxaban (Xarelto) for treatment of deep vein thrombosis and prevention of venous thromboembolism recurrence
Rivaroxaban (Xarelto) is PBS listed as an alternative to parenteral anticoagulation with heparin and dose-adjusted warfarin for treatment of DVT and prevention of VTE recurrence.
Pregabalin (Lyrica) for neuropathic pain
Pregabalin is a treatment option to relieve pain and improve quality of sleep in postherpetic neuralgia and painful diabetic neuropathy.
Imiquimod cream (Aldara) for superficial basal cell carcinoma
Imiquimod is an option for the treatment of small, low-risk sBCC when surgery, curettage or cryotherapy are inappropriate.
Sitagliptin with simvastatin (Juvicor) fixed-dose combination therapy for type 2 diabetes and hypercholesterolaemia
Juvicor is a fixed-dose combination medicine containing sitagliptin and simvastatin for treating type 2 diabetes and hypercholesterolaemia.
Brief item: Femme-Tab ED 20/100 low-dose-oestrogen combined oral contraceptive
The low-oestrogen-dose combined oral contraceptive levonorgestrel with ethinyloestradiol (Femme-Tab ED 20/100) was listed on the Pharmaceutical Benefits Scheme on 1 April 2013. It was delisted in May 2013.
Brief item: PBS listing for strontium ranelate (Protos) extended to include men with osteoporosis
From 1 April 2013 the Pharmaceutical Benefits Scheme listing of the anti-resorptive agent strontium ranelate is extended to include treatment of osteoporosis in men.
Brief item: Durotram (tramadol extended release) PBS listing deleted
Durotram has been deleted from the list of drugs subsidised on the Pharmaceutical Benefits Scheme.